NJ Advisory Bluechip

Scheme Rating

IME Scheme Rating

The Scheme does not meet our selection criteria at this time

Not a recommended fund: This is not a recommended fund, primarily because the AMC does not meet our selection criteria. We believe that there are better fund houses to invest in, within the Indian mutual fund universe.

IME Strategy Rating

Multicap Strategy: Equity investment in well-established companies within the top-300 market-cap based on ROCE, ROE, revenue growth, and free-cash-flow top 15 companies selected and rebalancing every year.

PMS Scheme Ratings are driven by IME’s Proprietary Scheme Rating Methodology, which takes into account our ratings of the Scheme’s investment strategy, its maturity, the investment team, and our separate rating on the AMC that runs this particular scheme. Our views on each of these individual criteria are available via the IME RMS – which you can view by reaching out to one of our relationship managers (using either the live chat or book appointment feature on this site).

IME View on NJ Advisory Bluechip

Type: Large & Midcap | GARP | AUM (1741.6 cr) | Inc Date (12 Mar 2018)

NJ Advisory Bluechip- Investment Strategy

NJ Asset Management Bluechip is a multi-cap strategy. Investments in 15 companies from the top-300 market-cap universe. The strategy rebalances the portfolio yearly.

Trailing Performance

1yr 3yr 5yr Since Inception
NJ Advisory Bluechip 28.5 17.3 17.9 15
S&P BSE 500 TRI 39.5 19.5 19 14.7
Alpha over Broad Mkt BM -11 -2.2 -1.1 0.3
Nifty 500 38.4 18.1 17.5
Alpha over Category BM -9.9 -0.8 0.4

Performance as of: 28-Feb-23 | Inception Date: 12-Mar-18

Fund Managers

Viral Shah | 2-star rated FM

Fund Manager

Mr. Viral Shah. He has close to 20 years of experience in Investments research and funds management. He has been associated with the group since the last 17 years. He has been responsible for setting up and running the funds management practice at NJPMS since 2010. He’s also the Principal officer for the business. He specializes in building and running Quantitative and Rules Based investment models and products that have been running at NJPMS since its inception. His analytical bent of mind and his capability to setup models for Rules based investment has been very useful in creating a robust investment process as a part of the business. The unique product range that he’s spearheaded in terms of launch and management have been hailed as unique and have helped NJPMS create a separate space for itself.

Fee Structure

Fee StructureFee
Fixed Fee Structure2.5
Variable Fee Structures
Exit Fees1yr(1%)


AMC: NJ Advisory PMS (click link for detailed AMC review)

Not a recommended AMC: NJ has managed to scale its PMS business primarily on the back of its access to one of the largest distribution networks in India. However, with an extremely limited investment pedigree (at the group or fund manager level) this is a PMS that we would recommend that investors stay away from.

NJ Advisory PMS does not meet our criteria for PMS AMC Selection at this time. Understand our AMC rating criteria at AMC Rating Criteria or contact us via the LiveChat to learn more.

Get substantially greater insights by connecting with us!

Details shared on the public website, are only a short snapshot of the more detailed analysis that resides in our Proprietary Research Management Solution (RMS) – A proprietary cloud-based tool, that ensures that the unbiased research insights of our central research team are shared directly with investors.

Our RMS allows us to operate with a level of transparency, ethics & consistency of insights, that is unparrarelled in the industry. Our RM’s will help showcase the PMS/AIF options that are the most suited for your unique requirements.

Download Sample RMS Reports: AMC View | Scheme Comparison

Note: PMS AMC & Scheme Reviews and Ratings are based on IME Capital’s Proprietary Review and Rating Methodology (read more here: AMC Rating & Scheme Ratings). These reflect the unbiased views of our central research team, based on our assessment of the investment value of these PMS/AIF strategies for our investors. We follow a highly stringent rating-criteria, where approximately 50% of PMS AMC’s & strategies would be rated 2-star or below (this is not meant to indicate that these funds are not investment-worthy, but that they do not currently fulfill the requirements we focus on for recommending funds to our investors — based on our internal views on the merit of the AMC/strategy relative to peers). Reviews & Ratings are primarily based on research of publicly available information (SEBI disclosures, PMS websites, PMS-aggregation platforms, webinar recording, media interviews etc.) and no explicit consent is required from AMCs for the same. While we endeavour to do further due-diligence via direct interactions with the investment teams of AMCs, this is typically restricted to AMC’s that meet our foundational fund selection criteria (reviews on lower-rated AMCs are often based solely on publicly available information). The views reflected in our Reviews & Ratings, are our independent views and may not be shared by the AMC’s and the investment teams. Please read detailed disclaimer for more.